|
��չ����
|
|
| ������Ϣ | |
 |
Supporting info |
|
PDFȫ�� |
|
[HTMLȫ��] |
|
����� |
| �����뷴�� | |
|
�������ù����� |
|
���� |
|
Email Alert |
|
���·��� |
|
���������Ϣ |
| ���Ĺؼ���������� | |
|
�ǵ��� |
|
�м�˿ |
|
���� |
|
ͻ�� |
|
Ƥ������,�Ŵ��� |
| ��������������� | |
|
������ |
|
��¡�� |
| PubMed | |
|
Article by |
|
Article by |
�ǵ�������Ŵ���Ƥ����
������, ��¡��
�й�ҽѧ��ѧԺ���й�Э��ҽ�ƴ�ѧƤ�����о��� �Ͼ� 210042
�ǵ����ǽ����γ�ϸ������Ҫ�ṹ����,�ǹ���ϸ���Ǽ��м�˿����Ҫ����֮һ,�Ǣ��͡����ͽǵ���������Ա����м�˿����,������������Ƥϸ���б��,�����ض���ϸ���гɶԱ������ǵ����ǵ�������Ŵ���Ƥ�������ٴ����֡���������ѧ�о���չ,ּ�ڽ�ʾ�䷢������,Ϊ��չ��ǰ��ϼ����Ļ������Ƶ춨���ۻ�����
[2] Smith TA, Strelkov SV, Burkhard P,et al. Sequence comparisons of intermediate filament chains: evideuce of a unique functional/structural role for coiled-coil segment lA and linker L1. J Struct Biol,2002, 137:128-145.
[3] Nakano A, Pfendner E, Hashimoto 1, et al. Herlitz junctional epidermolysis bullosa: novel and recurrent mutations in the LAMB3 gene and the population carrier frequency. J Invest Dermatol, 2000, 115:493-498.
[4] Chen H, Bonifas JM, Matsumura K, et al. Keratin 14 gene mutations in patients with epidermolysis bullosa simplex. J Invest Dermatol,1995, 105:629-632.
[5] Corden LD, McLean WH. Human keratin diseases: hereditary fragility of specific epithelial tissues. Exp Dermatol, 1996, 5:297-307.
[6] Liovic M, Stojan J, Bowden PE, et al. A novel keratin 5 mutation (K5V186L) in a family with EBS-K: a conservative substitution can lead to developnent of different disease phenotypes. J Invest Dermatol, 2001, 116:964-969.
[7] Cummins RE, Klingberg S, Wesley J, et al. Keratin 14 point mutations at codon 119 of helix 1A resulting in different epidermolysis bullosa simplex phenotypes. J Invest Dermatol, 2001, 117: 1103-1107.
[8] Ciubotaru D, Bergnan R, Baty D, et al. Epidermolysis bullosa simplex in Israel: clinical and genetic features. Arch Dermatol, 2003,139:498-505.
[9] DiGiovanna JJ, Bale SJ. Epidermolytic hyperkeratosis: applied molecular genetics. J Invest Dermatol, 1994, 102:390-394.
[10] Yang JM, Nam K, Kim SW, et al. Arginine in the beginning of the 1A rod domain of the keratin 10 gene is the hot spot for the mutation in epidermolytic hyperkeratosis. J Dermatol Sci, 1999, 19:126-133.
[11] Joh GY, Traupe H, Metze D, et al. A novel dinucleotide mutation in keratin 10 in the annular epidermolytic ichthyosis variant of bullous congenital ichthyosiform erythroderma. J Invest Dermatol, 1997, 108:357-361.
[12] Smith F. The molecular genetics of keratin disorders. Am J Clin Dermatol, 2003, 4:347-364.
[13] Terrinoni A, Smith FJ, Didona B, et al. Novel and recurrent mutations in the genes encoding keratins K6a, K16 and K17 in 13 cases of pachyonychia congenita. J Invest Dermatol, 2001, 117:1391-1396.
[14] Covello SP, Smith FJ, Sillevis Smitt JH, et al. Keratin 17 mutations cause either steatocystoma multiplex or pachyonychia congenita type 2. Br J Dermatol, 1998, 139:475-480.
[15] Coleman CM, Munro CS, Smith FJ, et al. Epidermolytic palmoplantar keratoderma due to a novel type of keratin mutation, a 3-bp insertion in the keratin 9 helix termination motif. Br J Dermatol, 1999,140:486-490.
[16] Shamsher MK, Navsaria HA, Stevens HP, et al. Novel mutations in keratin 16 gene underly focal non-epidermolytic palmoplantar keratoderma (NEPPK) in two families. Hum Mol Genet, 1995, 4:1875-1881.
[17] Kimonis V, DiGiovanna JJ, Yang JM, et al. A mutation in the Vlend domain of keratin 1 in non-epidermolytic palmar-plantar keratoderma. J Invest Dermatol, 1994, 103:764-769.